Literature DB >> 27575857

Staging model raises fundamental questions about the nature of bipolar disorder.

Martin Alda1, Flavio Kapczinski1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27575857      PMCID： PMC5008917          DOI： 10.1503/jpn.160151

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  20 in total

1.  The potential utility of a staging model as a course specifier: a bipolar disorder perspective.

Authors:  Michael Berk; Karen T Hallam; Patrick D McGorry
Journal:  J Affect Disord       Date:  2007-04-11       Impact factor: 4.839

Review 2.  The phenotypes of bipolar disorder: relevance for genetic investigations.

Authors:  G M MacQueen; T Hajek; M Alda
Journal:  Mol Psychiatry       Date:  2005-09       Impact factor: 15.992

Review 3.  Beyond the guidelines for bipolar disorder: practical issues in long-term treatment with lithium.

Authors:  Cynthia Calkin; Martin Alda
Journal:  Can J Psychiatry       Date:  2012-07       Impact factor: 4.356

4.  Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?

Authors:  Michael Berk; Seetal Dodd
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

5.  Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention.

Authors:  Michael Berk; Alan Brnabic; Seetal Dodd; Katarina Kelin; Mauricio Tohen; Gin S Malhi; Lesley Berk; Philippe Conus; Patrick D McGorry
Journal:  Bipolar Disord       Date:  2011-02       Impact factor: 6.744

6.  Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial.

Authors:  Jan Scott; Eugene Paykel; Richard Morriss; Richard Bentall; Peter Kinderman; Tony Johnson; Rosemary Abbott; Hazel Hayhurst
Journal:  Br J Psychiatry       Date:  2006-04       Impact factor: 9.319

Review 7.  Pretreatment episode count and response to lithium treatment in manic-depressive illness.

Authors:  Irene M Bratti; Ross J Baldessarini; Christopher Baethge; Leonardo Tondo
Journal:  Harv Rev Psychiatry       Date:  2003 Sep-Oct       Impact factor: 3.732

8.  Clinical implications of a staging model for bipolar disorders.

Authors:  Flávio Kapczinski; Vasco Videira Dias; Marcia Kauer-Sant'Anna; Benicio Noronha Frey; Rodrigo Grassi-Oliveira; Francesc Colom; Michael Berk
Journal:  Expert Rev Neurother       Date:  2009-07       Impact factor: 4.618

9.  Early stages in the development of bipolar disorder.

Authors:  Anne Duffy; Martin Alda; Tomas Hajek; Simon B Sherry; Paul Grof
Journal:  J Affect Disord       Date:  2009-06-21       Impact factor: 4.839

10.  A familial risk enriched cohort as a platform for testing early interventions to prevent severe mental illness.

Authors:  Rudolf Uher; Jill Cumby; Lynn E MacKenzie; Jessica Morash-Conway; Jacqueline M Glover; Alice Aylott; Lukas Propper; Sabina Abidi; Alexa Bagnell; Barbara Pavlova; Tomas Hajek; David Lovas; Kathleen Pajer; William Gardner; Adrian Levy; Martin Alda
Journal:  BMC Psychiatry       Date:  2014-12-02       Impact factor: 3.630
View more
  7 in total

1.  Concepts and misconceptions regarding clinical staging models.

Authors:  Jai Shah; Jan Scott
Journal:  J Psychiatry Neurosci       Date:  2016-10       Impact factor: 6.186

2.  Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder.

Authors:  Andrea Murru; Isabella Pacchiarotti; Norma Verdolini; Maria Reinares; Carla Torrent; Pierre-Alexis Geoffroy; Frank Bellivier; Pierre-Michel Llorca; Eduard Vieta; Ludovic Samalin
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-05-22       Impact factor: 5.270

3.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

4.  Between wellness, relapse, and remission: Stages of illness in anorexia nervosa.

Authors:  Joanna E Steinglass; Deborah R Glasofer; Maya Dalack; Evelyn Attia
Journal:  Int J Eat Disord       Date:  2020-02-07       Impact factor: 5.791

5.  Does stage of illness influence recovery-focused outcomes after psychological treatment in bipolar disorder? A systematic review protocol.

Authors:  Hailey Tremain; Kathryn Fletcher; Jan Scott; Carla McEnery; Michael Berk; Greg Murray
Journal:  Syst Rev       Date:  2019-05-25

6.  Classification of patients with bipolar disorder using k-means clustering.

Authors:  Lorena de la Fuente-Tomas; Belen Arranz; Gemma Safont; Pilar Sierra; Monica Sanchez-Autet; Ana Garcia-Blanco; Maria P Garcia-Portilla
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

Review 7.  Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force.

Authors:  Ralph Kupka; Anne Duffy; Jan Scott; Jorge Almeida; Vicent Balanzá-Martínez; Boris Birmaher; David J Bond; Elisa Brietzke; Ines Chendo; Benicio N Frey; Iria Grande; Danella Hafeman; Tomas Hajek; Manon Hillegers; Marcia Kauer-Sant'Anna; Rodrigo B Mansur; Afra van der Markt; Robert Post; Mauricio Tohen; Hailey Tremain; Gustavo Vazquez; Eduard Vieta; Lakshmi N Yatham; Michael Berk; Martin Alda; Flávio Kapczinski
Journal:  Bipolar Disord       Date:  2021-07-23       Impact factor: 5.345
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.